Shingo Tsuji

Summary

Affiliation: University of Tokyo
Country: Japan

Publications

  1. pmc A simple knowledge-based mining method for exploring hidden key molecules in a human biomolecular network
    Shingo Tsuji
    Genome Science Division, Research Center for Advanced Science and Technology RCAST, The University of Tokyo, 4 6 1 Komaba, Meguro ku, Tokyo 153 8904, Japan
    BMC Syst Biol 6:124. 2012
  2. doi request reprint Genomic approach towards personalized anticancer drug therapy
    Yutaka Midorikawa
    Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, 4 6 1 Komaba, Meguro ku, Tokyo 153 8904, Japan
    Pharmacogenomics 13:191-9. 2012
  3. pmc PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer
    Teruyuki Sato
    Genome Science Division, Research Center for Advanced Science and Technology RCAST, The University of Tokyo, Tokyo, Japan
    Sci Rep 3:1911. 2013
  4. pmc H3F3A K27M mutations in thalamic gliomas from young adult patients
    Koki Aihara
    Corresponding authors Akitake Mukasa, MD, PhD, Department of Neurosurgery, The University of Tokyo Hospital, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan Hiroyuki Aburatani, MD, PhD, Genome Science Division, Research Center for Advanced Science and Technology RCAST, The University of Tokyo, 4 6 1 Komaba, Meguro ku, Tokyo 153 8904, Japan
    Neuro Oncol 16:140-6. 2014

Collaborators

Detail Information

Publications4

  1. pmc A simple knowledge-based mining method for exploring hidden key molecules in a human biomolecular network
    Shingo Tsuji
    Genome Science Division, Research Center for Advanced Science and Technology RCAST, The University of Tokyo, 4 6 1 Komaba, Meguro ku, Tokyo 153 8904, Japan
    BMC Syst Biol 6:124. 2012
    ..Although there are several network-based methods, which detect key nodes in the network, the results tend to include well-studied, major hub genes...
  2. doi request reprint Genomic approach towards personalized anticancer drug therapy
    Yutaka Midorikawa
    Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, 4 6 1 Komaba, Meguro ku, Tokyo 153 8904, Japan
    Pharmacogenomics 13:191-9. 2012
    ....
  3. pmc PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer
    Teruyuki Sato
    Genome Science Division, Research Center for Advanced Science and Technology RCAST, The University of Tokyo, Tokyo, Japan
    Sci Rep 3:1911. 2013
    ..Treatment with EZH2 inhibitors, DZNep and GSK126, resulted in growth repression of SCLC cell lines. High PRC2 expression was suggested to contribute to gene repression in SCLC, and may play a role in genesis of SCLC...
  4. pmc H3F3A K27M mutations in thalamic gliomas from young adult patients
    Koki Aihara
    Corresponding authors Akitake Mukasa, MD, PhD, Department of Neurosurgery, The University of Tokyo Hospital, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan Hiroyuki Aburatani, MD, PhD, Genome Science Division, Research Center for Advanced Science and Technology RCAST, The University of Tokyo, 4 6 1 Komaba, Meguro ku, Tokyo 153 8904, Japan
    Neuro Oncol 16:140-6. 2014
    ..Here, we sought to determine the association between H3F3A mutations and adult thalamic glioma...